Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ATNM

Actinium Pharmaceuticals Inc

May 01 • 04:00PM ET

1.13

+0.02 1.80 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: AFMD APTO BLRX CLLS CUE IMMP KPTI PSTX PDSB TGTX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.09	Insider Own	3.12%	Shs Outstand	31.20M	Perf Week	-11.72%
Market Cap	35.45M	Forward P/E	-	EPS next Y	-0.88	Insider Trans	0.00%	Shs Float	30.40M	Perf Month	14.14%
Enterprise Value	-10.86M	PEG	-	EPS next Q	-0.23	Inst Own	19.69%	Short Float	3.60%	Perf Quarter	-2.59%
Income	-33.89M	P/S	393.89	EPS this Y	16.74%	Inst Trans	0.63%	Short Ratio	6.27	Perf Half Y	-22.60%
Sales	0.09M	P/B	4.50	EPS next Y	3.03%	ROA	-52.50%	Short Interest	1.09M	Perf YTD	-16.91%
Book/sh	0.25	P/C	0.74	EPS next 5Y	20.07%	ROE	-166.96%	52W High	1.95 -41.91%	Perf Year	-24.16%
Cash/sh	1.53	P/FCF	-	EPS past 3/5Y	7.39% 9.91%	ROIC	-384.82%	52W Low	0.95 18.70%	Perf 3Y	-87.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-54.09% -	Gross Margin	-812.22%	Volatility	4.84% 8.16%	Perf 5Y	-85.25%
Dividend TTM	-	EV/Sales	-120.67	EPS Y/Y TTM	14.71%	Oper. Margin	-40274.44%	ATR (14)	0.09	Perf 10Y	-98.00%
Dividend Ex-Date	-	Quick Ratio	6.20	Sales Y/Y TTM	11.11%	Profit Margin	-37652.22%	RSI (14)	44.90	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.20	EPS Q/Q	10.69%	SMA20	-7.49%	Beta	-0.11	Target Price	5.75
Payout	-	Debt/Eq	0.22	Sales Q/Q	-	SMA50	-1.99%	Rel Volume	0.83	Prev Close	1.11
Employees	25	LT Debt/Eq	0.12	Earnings	Mar 13	SMA200	-19.35%	Avg Volume	174.54K	Price	1.13
IPO	Jun 02, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.77% -	Trades		Volume	145,598	Change	1.80%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)